Varicella zoster virus the ACIP recommended a second dose of vaccine before school entry to ensure the maintenance of high levels of varicella immunity. In 2006, the United States Food and Drug Administration approved Zostavax for the prevention of shingles. Zostavax is a more concentrated formulation of the Varivax vaccine, designed to elicit an immune response in older adults whose immunity to VZV wanes with advancing age. A systematic review by the Cochrane Library shows that Zostavax reduces the incidence of shingles by almost 50%. Shingrix is a "V. zoster" vaccine developed by GlaxoSmithKline which was approved in the United States by the
National Centre for Disease Control centers in India, which started surveillance of HIV infection in the country. On 30 July 2009, it was named as National Centre for Disease Control. NCDc has eight divisions under it namely Doctors from NCDC had been previously summoned to investigate potential outbreaks of diseases including suspected cases of Pneumonic plague in Punjab in 2002, SARS outbreaks in 2004, meningitis outbreak in Delhi in 2005, and avian influenza in 2006. The NCDC in collaboration with the Centers for Disease Control and Prevention has set up the Global Disease Detection Regional Center in New Delhi, India. This will lead to long-term